The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Role of the ACM
The ACM provides independent medical and scientific advice to the Minister for Health and the Therapeutic Goods Administration (TGA) on issues relating to the safety, quality and efficacy of medicines supplied in Australia including issues relating to pre-market and post-market functions for medicines.
The Committee is established under Regulation 35 of the Therapeutic Goods Regulations 1990. Members are appointed by the Minister.
The ACM was established in January 2017, to encompass pre and post-market advice for medicines, following the consolidation of the previous functions of the Advisory Committee on Prescription Medicines (ACPM), the Advisory Committee on the Safety of Medicines (ACSOM) and the Advisory Committee on Non-Prescription Medicines (ACNM).
Membership comprises of professionals with specific scientific, medical or clinical expertise, as well as appropriate consumer health issues relating to medicines.
Membership
The current membership of the committee can be found on our ACM members page.
2025 ACM proposed meeting dates
| Meeting no. | Meeting dates |
|---|---|
| 49 | 6-7 February 2025 |
| 50 | 3-4 April 2025 |
| 51 | 5-6 June 2025 |
| 52 | 7-8 August 2025 |
| 53 | 2-3 October 2025 |
| 54 | 4-5 December 2025 |
Contact details for the ACM
| ACM enquiries | Committee support enquiries | |
|---|---|---|
| acm@health.gov.au | Committees@health.gov.au | |
| Postal Address | Advisory Committee on Medicines Therapeutic Goods Administration PO Box 100 WODEN ACT 2606 Attn: Prescription Medicines Authorisation Branch, MDP 122 | Committee Support Unit Therapeutic Goods Administration PO Box 100 WODEN ACT 2606 Attn: Regulatory Engagement Branch, MDP 122 |